Entrada Therapeutics, Inc. (TRDA)

CIK 1689375 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Entrada Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 2026SCHEDULE 13D/A0001231919-26-001160
Sep 9, 202640001231919-26-001155
Sep 9, 202640001231919-26-001156
Sep 3, 202640001613084-26-000004
Sep 3, 202640001873392-26-000006
Sep 3, 202640001231919-26-001144
Sep 3, 202640001231919-26-001143
Sep 3, 202640001725663-26-000007
Sep 3, 202640001873394-26-000005
Aug 31, 202640001231919-26-001136
Aug 31, 202640001231919-26-001135
Aug 26, 202640001231919-26-001106
Aug 26, 202640001231919-26-001107
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352315
Aug 10, 202640001664281-26-000004
Aug 10, 202640001231919-26-000854
Aug 10, 2026144/A0001674324-26-000008
Aug 5, 20268-K0001689375-26-000052
Aug 5, 202610-Q0001689375-26-000054
Aug 3, 202640001231919-26-000822
Aug 3, 202640001664281-26-000002
Jul 30, 20261440001674324-26-000006
Jun 12, 202640001689375-26-000047
Jun 12, 202640001689375-26-000034
Jun 12, 202640001689375-26-000036